Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hooper Anthony C
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   618,962    

Indirect Shares

   5,248      
Direct Value   $79,212,041    

Indirect Value

   $219,104      
Total Shares   624,210      
Total Value   $79,431,145      


Bristol-Myers Squibb Co $8,482,348 Amgen Inc $66,129,733 MannKind Corp $801,496 Beigene Ltd $3,798,464 Bristol-Myers Squibb Co $8,482,348 Amgen Inc $66,129,733 MannKind Corp $801,496 Beigene Ltd $3,798,464
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   58.4%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY SVP ComOps Pres USJap ... 2011-05-13 203,170 2011-05-13 5,248    Premium*  
            Amgen Inc AMGN EVP, Global Commercial... 2018-05-03 215,147 2011-10-27 0    Premium*  
            MannKind Corp MNKD Director 2024-02-04 176,153 0    Premium*  
            Beigene Ltd BGNE Director 2022-06-22 24,492 2021-06-16 0    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-03-04 4 D $26.43 $53,415 D/D (2,021) 160,673 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2006-06-20 4 D $25.48 $61,942 D/D (2,431) 113,165 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-07 4 D $24.60 $71,857 D/D (2,921) 112,382 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2007-06-20 4 D $31.23 $75,920 D/D (2,431) 95,549 0 -
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-03-07 4 D $26.31 $76,852 D/D (2,921) 162,428 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2008-09-19 4 D $21.00 $81,291 D/D (3,871) 94,588 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2008-09-10 4 D $21.67 $83,906 D/D (3,872) 98,459 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2009-09-21 4 D $22.52 $87,175 D/D (3,871) 99,837 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-01-30 4 D $157.16 $93,982 D/D (598) 187,973 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-06 4 D $24.60 $99,409 D/D (4,041) 115,303 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2016-01-31 4 D $152.73 $99,427 D/D (651) 163,962 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-01-31 4 D $154.43 $103,159 D/D (668) 187,305 0 -
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-03-06 4 D $26.43 $106,804 D/D (4,041) 165,349 0 -
BMY Bristol-Myers Squibb Co SVPComOps PresUSJapInterc   •       –      –    2010-09-20 4 D $27.81 $107,430 D/D (3,863) 108,519 0 -
MNKD MannKind Corp Director   –       •      –    2022-02-28 4 B $2.71 $108,400 D/D 40,000 338,394 2.39 %
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2018-01-30 4 D $198.00 $113,850 D/D (575) 203,134 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2018-01-31 4 D $191.27 $124,517 D/D (651) 202,483 0 -
MNKD MannKind Corp Director   –       •      –    2024-02-04 4 A $3.27 $130,800 D/D 40,000 176,153 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2018-05-03 4 D $169.43 $149,607 D/D (883) 215,147 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2016-01-28 4 D $150.47 $149,718 D/D (995) 164,339 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-01-28 4 D $158.89 $152,376 D/D (959) 113,952 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-01-28 4 D $157.16 $165,489 D/D (1,053) 188,571 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-04-27 4 D $111.41 $172,240 D/D (1,546) 114,664 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-06 4 OE $24.60 $214,438 D/D 8,717 119,344 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2009-02-19 4/A D $20.51 $246,099 D/D (11,999) 108,419 0 -
  93  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us